EXHIBIT 10.71
This document contains confidential information which is not
being provided to the Public.
[XXXXXX HEALTHCARE CORPORATION LETTERHEAD]
October 25, 2001
Xx. Xxxxx Xxxxxx
Senior Vice President
Coram, Inc.
0000 00xx Xxxxxx, Xxxxx 0000
Xxxxxx, XX 00000
Re: Coram / 34251865
Pre-Filled Syringe & Rocephin Tier Pricing
Dear Xx. Xxxxxx:
Your Medication Delivery (formally known as I.V. Systems) Purchase Agreement
with Xxxxxx Healthcare Corporation indicates a Pre-Filled Syringe and Rocephin
price tier change on each November 1 and May 1.
Your Purchase Agreement states that Baxter shall review Coram's purchases of
flush syringes and frozen drug products every October 1 and April 1 of each
year. Based upon Xxxxx'x purchases during the six-month period, Coram's pricing
shall be adjusted to the applicable tier for purchases during the next period to
become effective on November 1 and May 1.
The Pre-Filled Syringe Tier shall remain at the initial pricing of Tier 2 per
the directive of Xxxx Xxxxxxx, ACT National Accounts Director, due to the
back-order situation that occurred in the preceding six-month period.
Based upon the total frozen sales for period April 1, 2001 through September 30,
2001 of Coram is now eligible for Rocephin Tier 1 pricing, committed volume of
in sales. Rocephin Tier 1 pricing shall become effective November 1, 2001.
Should you have any questions regarding this agreement, please contact Xxxx
Xxxxxxx, ACT National Accounts Director at (800) 285-3536 ext. 7597.
Sincerely,
/s/ XXXXXXX X. XXXXXXXXX
Xxxxxxx X. Xxxxxxxxx
Sales Contact Administrator
cc: Xxxx Xxxxxxx
Xxxx Xxxxxxxxxx
File
